Upgrade to SI Premium - Free Trial

CervoMed (CRVO) PT Lowered to $18 at Canaccord

August 10, 2026 7:00 AM
(Updated - August 10, 2026 7:29 AM EDT)

Canaccord analyst Sumant Kulkarni lowered the price target on CervoMed (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change